ICU Medical, Inc. (ICUI) has a MoatMap StockRank of 77/100 based on Quality (53/100), Value (48/100), and Momentum (59/100) factor scores. The current signal is BUY. ICU Medical, specializing in critical care and infusion therapy, is a prime 'Durable Quality & Moats' business, offering mission-critical products with high switching costs for hospitals (integration, training, patient safety). This durable moat, coupled with recurring consumable revenue, grants strong pricing power and high returns on capital, creating an asymmetric opportunity as the market often undervalues such indispensable healthcare compounders for more headline-grabbing names.
ICU Medical, Inc. is a medical technology company specializing in the development, manufacture, and sale of innovative medical devices and software for infusion therapy and critical care. The company's portfolio, including IV sets, pumps, and safety devices, addresses crucial needs in high-acuity environments, establishing high switching costs for healthcare providers. Its commitment to patient safety and clinical outcomes reinforces its strong market position within this essential healthcare niche.
| Price | $134.97 |
| Market Cap | $3.3B |
| P/E (TTM) | 72.56 |
| P/E (Forward) | 14.46 |
| Price/Book | 1.60 |
| Return on Equity | 2.3% |
| Return on Invested Capital | 2.8% |
| Debt/Equity | 63.62 |
| Gross Margin | 37.9% |
| Operating Margin | 5.7% |
| Revenue Growth | -12.3% |
| Free Cash Flow | $387M |
ICU Medical, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).